ClariVest Asset Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

ClariVest Asset Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-112,730	Closed	-$3.75M	–	888
2020 Q2	$3.75M	Buy	112,730 +75,385	+202%	+$2.4M	0.1%	147
2020 Q1	$1.01M	Buy	+37,345	New	+$1.04M	0.03%	294
2016 Q3	–	Sell	-32,613	Closed	-$353K	–	765
2016 Q2	$353K	Buy	32,613 +4,400	+16%	+$45.4K	0.01%	407
2016 Q1	$260K	Buy	28,213 +1,127	+4%	+$12.1K	0.01%	432
2015 Q4	$402K	Sell	27,086 -636	-2%	-$10.6K	0.01%	371
2015 Q3	$454K	Sell	27,722 -600	-2%	-$12.3K	0.01%	335
2015 Q2	$645K	Buy	+28,322	New	+$564K	0.02%	319
2014 Q3	–	Sell	-58,102	Closed	-$701K	–	635
2014 Q2	$701K	Buy	58,102 +74	+0.1%	+$874	0.03%	255
2014 Q1	$676K	Buy	+58,028	New	+$983K	0.03%	247
2013 Q4	–	Sell	-5,265	Closed	-$76K	–	667
2013 Q3	$76K	Buy	+5,265	New	+$80.6K	﹤0.01%	422

Other funds holding MNTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

ClariVest Asset Management's MNTA Position: Q3 2020 in Review

ClariVest Asset Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 112,730 shares — an estimated $3.75M sold.

ClariVest Asset Management first reported a position in MNTA in Q3 2013 and held it in 10 quarters. The position peaked at $3.75M in Q2 2020. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

ClariVest Asset Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
ClariVest Asset Management sold 112,730 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $3.75M.
ClariVest Asset Management first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2013 and held it in 10 quarters.
ClariVest Asset Management's Momenta Pharmaceuticals, Inc. position peaked at $3.75M in Q2 2020.
211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on ClariVest Asset Management's 13F filing for Q3 2020, filed 9 Nov 2020.